pyruvaldehyde has been researched along with Chronic Kidney Diseases in 9 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Uremic sarcopenia is a serious clinical problem associated with physical disability and increased morbidity and mortality." | 1.72 | Methylglyoxal Induces Inflammation, Metabolic Modulation and Oxidative Stress in Myoblast Cells. ( Hosoda, Y; Miyazaki, M; Mori, T; Sato, E; Sato, H; Sekimoto, A; Takahashi, N; Todoriki, S; Watanabe, M; Yamamoto, T, 2022) |
| "Adenine-treated Sprague-Dawley rats were randomly assigned to receive continuous peritoneal injections of PDF with or without MGO for three weeks or were left untreated for the same duration." | 1.40 | Peritoneal fibrosis induced by intraperitoneal methylglyoxal injection: the role of concurrent renal dysfunction. ( Akimoto, T; Hirahara, I; Inoue, M; Kusano, E; Morishita, Y; Nagata, D; Onishi, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Todoriki, S | 1 |
| Hosoda, Y | 1 |
| Yamamoto, T | 1 |
| Watanabe, M | 1 |
| Sekimoto, A | 1 |
| Sato, H | 1 |
| Mori, T | 1 |
| Miyazaki, M | 1 |
| Takahashi, N | 1 |
| Sato, E | 1 |
| Rabbani, N | 1 |
| Adaikalakoteswari, A | 1 |
| Larkin, JR | 1 |
| Panagiotopoulos, S | 1 |
| MacIsaac, RJ | 1 |
| Yue, DK | 1 |
| Fulcher, GR | 1 |
| Roberts, MA | 1 |
| Thomas, M | 1 |
| Ekinci, E | 1 |
| Thornalley, PJ | 1 |
| Pácal, L | 1 |
| Chalásová, K | 1 |
| Pleskačová, A | 1 |
| Řehořová, J | 1 |
| Tomandl, J | 1 |
| Kaňková, K | 1 |
| Hanssen, NMJ | 1 |
| Stehouwer, CDA | 1 |
| Schalkwijk, CG | 1 |
| Tezuka, Y | 1 |
| Nakaya, I | 1 |
| Nakayama, K | 1 |
| Nakayama, M | 1 |
| Yahata, M | 1 |
| Soma, J | 1 |
| Senda, M | 1 |
| Ogawa, S | 1 |
| Nako, K | 1 |
| Okamura, M | 1 |
| Sakamoto, T | 1 |
| Ito, S | 1 |
| Onishi, A | 1 |
| Akimoto, T | 1 |
| Morishita, Y | 1 |
| Hirahara, I | 1 |
| Inoue, M | 1 |
| Kusano, E | 1 |
| Nagata, D | 1 |
| Jensen, TM | 1 |
| Vistisen, D | 1 |
| Fleming, T | 1 |
| Nawroth, PP | 1 |
| Rossing, P | 1 |
| Jørgensen, ME | 1 |
| Lauritzen, T | 1 |
| Sandbaek, A | 1 |
| Witte, DR | 1 |
| Linden, E | 1 |
| Cai, W | 1 |
| He, JC | 1 |
| Xue, C | 1 |
| Li, Z | 1 |
| Winston, J | 1 |
| Vlassara, H | 1 |
| Uribarri, J | 1 |
1 review available for pyruvaldehyde and Chronic Kidney Diseases
| Article | Year |
|---|---|
Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease.
Topics: Diabetic Nephropathies; Humans; Lactoylglutathione Lyase; Pyruvaldehyde; Renal Insufficiency, Chroni | 2019 |
1 trial available for pyruvaldehyde and Chronic Kidney Diseases
| Article | Year |
|---|---|
Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic N | 2016 |
7 other studies available for pyruvaldehyde and Chronic Kidney Diseases
| Article | Year |
|---|---|
Methylglyoxal Induces Inflammation, Metabolic Modulation and Oxidative Stress in Myoblast Cells.
Topics: Adenosine Triphosphate; Animals; Female; Humans; Indican; Inflammation; Male; Mice; Muscular Atrophy | 2022 |
Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease.
Topics: Cross-Sectional Studies; Diabetes Mellitus; Diabetic Nephropathies; Glycation End Products, Advanced | 2022 |
Deleterious Effect of Advanced CKD on Glyoxalase System Activity not Limited to Diabetes Aetiology.
Topics: Aged; Case-Control Studies; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Lactoylglutat | 2018 |
Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetic Nephropathies; Disease P | 2019 |
The strong relation between post-hemodialysis blood methylglyoxal levels and post-hemodialysis blood glucose concentration rise.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Insulin; Lunch; | 2015 |
Peritoneal fibrosis induced by intraperitoneal methylglyoxal injection: the role of concurrent renal dysfunction.
Topics: Adenine; Animals; Body Weight; Kidney Function Tests; Matrix Metalloproteinase 2; Peritoneal Fibrosi | 2014 |
Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.
Topics: Adult; Aged; Case-Control Studies; Cells, Cultured; Cross-Sectional Studies; Endothelial Cells; Endo | 2008 |